Publications
2024
Bagnolini G., Poppi L., Previtali V., Ferrandi G., Rinaldi F., Girotto S., Hirsch A.K.H., Roberti M., Cavalli A.
A journey through targeting BRCA2-RAD51 protein-protein interaction to establish synthetic lethality as paradigm for anticancer drug discovery
National Congress of the Italian Chemistry Society 2024
Poster
Conference
2024
Myers S.H., Poppi L., Rinaldi F., Veronesi M., Ciamarone A., Previtali V., Bagnolini G., Schipani F., Ortega Martinez J.A., Girotto S., Di Stefano G., Farabegoli F., Walsh N., De Franco F., Roberti M., Cavalli A.
An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer
European Journal of Medicinal Chemistry, vol. 265
2024
Rinaldi F., Bernetti M., Bresciani V., Girotto S., Cavalli A.
An integrated structural approach reveals novel insights on the BRCA2 - RAD51 interaction
EMBO Practical Course on Small Angle Neutron and X-ray Scattering from biomacromolecules in solution
Poster
Conference
2024
Balboni B., Marotta R., Rinaldi F., Milordini G., Varignani G., Girotto S., Cavalli A.
An integrative structural study of the human full-length RAD52 at 2.2 Å resolution
Communications Biology, vol. 7, (no. 1)
2024
Bresciani V., Rinaldi F., Bernetti M., Masetti M.
Combining computational and experimental methods to characterize the RAD51-BRC repeats interaction
The 4th Masbic Annual Symposium
Poster
Conference
2024
Bresciani V., Rinaldi F., Bernetti M., Masetti M.
Elucidating the RAD51-BRC repeats interaction by integrating computational and experimental approaches
Summer School on Biomolecular Simulations
Poster
Conference
2024
Previtali V., Bagnolini G., Ciamarone A., Ferrandi G., Rinaldi F., Myers S.H., Roberti M., Cavalli A.
New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives
Journal of Medicinal Chemistry
2024
Rinaldi F., Girotto S.
Structure-based approaches in synthetic lethality strategies
Current Opinion in Structural Biology, vol. 88
2023
Poppi L., Myers S.H., Previtali V., Rinaldi F., Farabegol F., Di Stefano G., Walsh N., Roberti M., Cavalli A.
A RAD51/BRCA2 small molecule inhibitor enhances the antineoplastic effect of the PARPi talazoparib in pancreatic cancer
EACR
2023
Rinaldi F., Bernetti M., Bresciani V., Girotto S., Cavalli A.
Dissecting the BRCA2 - RAD51 interaction by integrating computational and experimental biophysics
EMBO Practical Course Integrative modelling of protein interactions
Poster
Conference
2023
Rinaldi F., Bernetti M., Bresciani V., Girotto S., Cavalli A.
Integration of computational and experimental biophysics reveals novel insights on the BRCA2 - RAD51 interaction
EMBO Workshop: Computational structural biology
Poster
Conference
2023
Rinaldi F., Schipani F., Balboni B., Catalano F., Marotta R., Myers S.H., Previtali V., Veronesi M., Scietti L., Cecatiello V., Pasqualato S., Ortega J.A., Girotto S., Cavalli A.
Isolation and Characterization of Monomeric Human RAD51: A Novel Tool for Investigating Homologous Recombination in Cancer
Angewandte Chemie - International Edition, vol. 62, (no. 51)
2023
Balboni B., Rinaldi F., Previtali V., Ciamarone A., Girotto S., Cavalli A.
Novel Insights into RAD52’s Structure, Function, and Druggability for Synthetic Lethality and Innovative Anticancer Therapies
Cancers, vol. 15, (no. 6)
2023
Rinaldi F.
Unveiling the molecular mechanism of BRCA2-RAD51 interaction to tackle cancer onset,
PhD Thesis
Book
2022
Myers S. H., Previtali V., Poppi L., Rinaldi F., Schipani F., Ortega J. O., De Franco F., Veronesi M., Pellicciari R., Roberti M., Girotto S., Di Stefano G., Cavalli A.
Identification and subsequent development of RAD51 inhibitors as potential tools in exploring BRCA2-PARP mediated synthetic lethality
ACS Spring 2022 meeting
Poster
Conference